返回 
加入收藏
胰岛素专项集采对我国胰岛素日费用和可负担性的影响研究
x
请在关注微信后，向客服人员索取文件
| 篇名： | 胰岛素专项集采对我国胰岛素日费用和可负担性的影响研究 |
| TITLE： | Study on the impact of the specialized centralized procurement for insulin on the daily cost and affordability of insulin in China |
| 摘要： | 目的 评估胰岛素专项集采政策对我国胰岛素日费用和可负担性的影响，为相关政策的完善提供数据支撑。方法通过各省份独立的药品集中采购平台收集胰岛素专项集采前后（2021年10－12月、2022年10－12月）的胰岛素采购数据，以各类胰岛素的限定日费用（DDDc）为指标，分析专项集采前后的日费用变化；以各类胰岛素年支出占年人均可支配收入的百分比（即年支出占比）为指标，评估专项集采前后各类胰岛素的可负担性变化。结果专项集采后，各类胰岛素DDDc的降幅为20.7%～71.8%，平均降幅为45.7%，且三代胰岛素的降幅超过二代胰岛素；胰岛素年支出占比的降幅为24.3%～73.4%，平均降幅为48.5%，预混胰岛素类似物的降幅最大（73.4%）。专项集采后，所有纳入省份的胰岛素DDDc均有所下降；除广西（10.2%）外，其余各省份胰岛素的平均年支出占比均降至10%以内。结论胰岛素专项集采政策显著降低了胰岛素费用、提高了可负担性、降低了糖尿病患者的经济负担，但省际及胰岛素类型间的日费用和可负担性差异明显，需重点关注。 |
| ABSTRACT： | OBJECTIVE To evaluate the impact of the specialized centralized procurement policy for insulin on daily cost and affordability of insulin， and provide data support for the enhancement of relevant policies. METHODS In this research， the insulin purchasing data were obtained from provincial centralized procurement platforms in provinces before and after the specialized centralized procurement of insulin （October-December 2021 and October-December 2022）， and the cost variations of insulin before and after the centralized procurement were analyzed by the defined daily dose cost （DDDc） of various types of insulins. The changes in the affordability of various types of insulins before and after the specialized centralized procurement were evaluated， using the percentage of annual expenditure on various types of insulins relative to annual per capita disposable income （i.e. the proportion of annual expenditure） as an indicator. RESULTS After the specialized centralized procurement， DDDc of various types of insulins decreased by 20.7%-71.8%， with an average reduction of 45.7%. Moreover， the reduction in DDDc for third-generation insulin exceeded that for second-generation insulin. The reduction in the proportion of annual expenditure on insulin ranged from 24.3% to 73.4%， with an average decrease of 48.5%. Premixed insulin analogs experienced the greatest reduction （73.4%）. Following the specialized centralized procurement， DDDc of insulin decreased in all provinces. Except for Guangxi （10.2%）， the average proportion of annual expenditure on insulin in the remaining provinces dropped to below 10%. CONCLUSIONS The specialized centralized procurement policy for insulin has significantly reduced insulin costs and improved affordability， thereby alleviating the economic pressure on patients with diabetes. There are notable cost disparities among provinces and among insulin categories， which require attention. |
| 期刊： | 2025年第36卷第12期 |
| 作者： | 雷凤萍；章洁琼；刘星宸；韦皓琪；刘星雨；杨才君 |
| AUTHORS： | LEI Fengping，ZHANG Jieqiong，LIU Xingchen，WEI Haoqi，LIU Xingyu，YANG Caijun |
| 关键字： | 胰岛素；国家专项集采；日费用；可负担性 |
| KEYWORDS： | insulin； national centralized procurement； daily cost； affordability |
| 阅读数： | 2 次 |
| 本月下载数： | 1 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
